A critical discovery in cancer investigation is emerging with the use of nanobodies to reactivate dysfunctional p53. This crucial cancer suppressor protein is frequently disabled in several types of malignancies, https://userbookmark.com/story21882541/vhh-fragments-revive-p53-new-promising-pathway-for-malignant-treatment